Steven Cohen's BMY Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 3 M shares of Bristol-Myers Squibb Company (BMY) worth $162.04 M, representing 0.18% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in BMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 3.34 M shares. Largest reduction occurred in Q2 2019, reducing 2.15 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Bristol-Myers Squibb Company (BMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bristol-Myers Squibb Company (BMY) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3 M | New Buy | 3 M | $53.94 |
| Q1 2025 | -1.41 M | Sold Out | 0 | $0.00 |
| Q4 2024 | -1.47 M | Reduce 51.04% | 1.41 M | $56.56 |
| Q3 2024 | +2.24 M | Add 351.46% | 2.88 M | $51.74 |
| Q2 2024 | +444,106 | Add 229.05% | 637,993 | $41.53 |
| Q1 2024 | +193,887 | New Buy | 193,887 | $54.23 |
| Q4 2023 | -765,327 | Sold Out | 0 | $0.00 |
| Q3 2023 | +756,964 | Add 9051.35% | 765,327 | $58.04 |
| Q2 2023 | +8,363 | New Buy | 8,363 | $63.95 |
| Q1 2023 | -499 | Sold Out | 0 | $0.00 |
| Q4 2022 | +499 | New Buy | 499 | $71.95 |
| Q4 2021 | -665,200 | Sold Out | 0 | $0.00 |
| Q3 2021 | +665,200 | New Buy | 665,200 | $59.17 |
| Q2 2021 | -259,100 | Sold Out | 0 | $0.00 |
| Q1 2021 | -1.22 M | Reduce 82.50% | 259,100 | $63.13 |
| Q4 2020 | +136,087 | Add 10.12% | 1.48 M | $62.03 |
| Q3 2020 | +680,135 | Add 102.36% | 1.34 M | $60.29 |
| Q2 2020 | +649,521 | Add 4349.57% | 664,454 | $58.80 |
| Q1 2020 | +14,933 | New Buy | 14,933 | $55.72 |
| Q3 2019 | -1.11 M | Sold Out | 0 | $0.00 |
| Q2 2019 | -2.15 M | Reduce 65.89% | 1.11 M | $45.35 |
| Q1 2019 | +947,784 | Add 40.98% | 3.26 M | $47.71 |
| Q4 2018 | +126,549 | Add 5.79% | 2.31 M | $51.98 |
| Q3 2018 | -1.23 M | Reduce 36.02% | 2.19 M | $62.08 |
| Q2 2018 | +3.34 M | Add 4455.86% | 3.42 M | $55.34 |
| Q1 2018 | -40,000 | Reduce 34.78% | 75,000 | $63.25 |
| Q4 2017 | +40,000 | Add 53.33% | 115,000 | $61.28 |
| Q3 2017 | -25,000 | Reduce 25.00% | 75,000 | $63.75 |
| Q2 2017 | -52,500 | Reduce 34.43% | 100,000 | $55.72 |
| Q1 2017 | +152,500 | New Buy | 152,500 | $54.38 |
| Q3 2016 | -470,600 | Sold Out | 0 | $0.00 |
| Q2 2016 | -61,500 | Reduce 11.56% | 470,600 | $73.55 |
| Q1 2016 | -732,100 | Reduce 57.91% | 532,100 | $63.88 |
| Q4 2015 | +165,200 | Add 15.03% | 1.26 M | $68.79 |
| Q3 2015 | +249,800 | Add 29.42% | 1.1 M | $59.20 |
| Q2 2015 | +228,300 | Add 36.77% | 849,200 | $66.54 |
| Q1 2015 | +374,500 | Add 151.99% | 620,900 | $64.50 |
| Q4 2014 | +246,400 | New Buy | 246,400 | $59.03 |
| Q3 2014 | -3,900 | Sold Out | 0 | $0.00 |
| Q2 2014 | +3,900 | Add 0.00% | 3,900 | $48.46 |
Steven Cohen's Bristol-Myers Squibb Company Investment FAQs
Steven Cohen first purchased Bristol-Myers Squibb Company (BMY) in Q2 2014, acquiring 3,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Bristol-Myers Squibb Company (BMY) for 40 quarters since Q2 2014.
Steven Cohen's largest addition to Bristol-Myers Squibb Company (BMY) was in Q2 2018, adding 3,416,898 shares worth $189.09 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 3,004,111 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $162.04 M.
As of the Q4 2025 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.18% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Bristol-Myers Squibb Company (BMY) was 3,416,898 shares, as reported at the end of Q2 2018.